Journal of Biological Chemistry · 2013 · 19 citations · 39 references
Life SciencesCell BiologyImmunologyCell SignalingHost-pathogen InteractionsInnate ImmunityImmune Responses To InfectionInflammatory SignalingInnate Immune ActivationInnate Immune ResponseInnate Immune Signaling PathwaysToll-like ReceptorsAntiviral Innate SignalingInnate Immune Signaling ModulationMitogen-activated Protein Kinase SignalingOligomerizationToll-like Receptor SignalingToll-like Receptor Signaling PathwaysToll-like Receptor-mediated Cytokine InductionToll-like Receptor-mediated Innate Immune Response
Vaccinia virus encodes a number of proteins that inhibit and manipulate innate immune signaling pathways that also have a role in virulence. These include A52, a protein shown to inhibit IL-1- and Toll-like receptor-stimulated NFκB activation, via interaction with interleukin-1 receptor-associated kinase 2 (IRAK2). Interestingly, A52 was also found to activate p38 MAPK and thus enhance Toll-like receptor-dependent IL-10 induction, which was TRAF6-dependent, but the manner in which A52 manipulates TRAF6 to stimulate p38 activation was unclear. Here, we show that A52 has a non-canonical TRAF6-binding motif that is essential for TRAF6 binding and p38 activation but dispensable for NFκB inhibition and IRAK2 interaction. Wild-type A52, but not a mutant defective in p38 activation and TRAF6 binding (F154A), caused TRAF6 oligomerization and subsequent TRAF6-TAK1 association. The crystal structure of A52 shows that it adopts a Bcl2-like fold and exists as a dimer in solution. Residue Met-65 was identified as being located in the A52 dimer interface, and consistent with that, A52-M65E was impaired in its ability to dimerize. A52-M65E although capable of interacting with TRAF6, was unable to cause either TRAF6 self-association, induce the TRAF6-TAK1 association, or activate p38 MAPK. The results suggest that an A52 dimer causes TRAF6 self-association, leading to TAK1 recruitment and p38 activation. This reveals a molecular mechanism whereby poxviruses manipulate TRAF6 to activate MAPKs (which can be proviral) without stimulating antiviral NFκB activation.
39
TAK1 is a ubiquitin-dependent kinase of MKK and IKK
Chen Wang, Li Deng, Mei Hong et al. · Nature · 2001 · 2.1K citations
Helical assembly in the MyD88–IRAK4–IRAK2 complex in TLR/IL-1R signalling
Su‐Chang Lin, Yu-Chih Lo, Hao Wu · Nature · 2010 · 1.1K citations
TAB2 and TAB3 Activate the NF-κB Pathway through Binding to Polyubiquitin Chains
Atsuhiro Kanayama, Rashu B. Seth, Lijun Sun et al. · Molecular Cell · 2004 · 869 citations · Full text
Distinct molecular mechanism for initiating TRAF6 signalling
Hong Ye, Joseph R. Arron, Betty Lamothe et al. · Nature · 2002 · 659 citations
Roman A. Laskowski · Nucleic Acids Research · 2008 · 588 citations · Full text